Implementing the Tobacco Control Act: Advice to the FDA
Scholars and practitioners from UCSF, UC Hastings, and elsewhere in California gathered at UC Hastings on August 28, 2009, to answer the FDA's request for advice on how it should implement the tobacco control act. Information about the panels and speakers at the program, sponsored by the UCSF/UC Hastings Consortium on Law, Science & Health Policy and the Hastings Science & Technology Law Journal, may be found below.
Read the advice given to the FDA.
Listen to the conference proceedings.
PowerPoint presentations used during the conference:
- Federal State and Local Government Collaboration
- Nicotine as a Basis for Tobacco Regulation, Dr. Neal Benowitz
- PFDA Oversight of Tobacco Products: The Good; The Bad; and The Ugly, Dr. Phillip Gardiner
- Special Populations: Smokers with Mental Health and Substance Abuse Disorders, Sharon Hall, Ph. D.
- Implementing the Tobacco Control Act: Advice to the FDA, Lisa Kroon, PharmD
- Hastings FDA Panel, Dr. Steve Schroeder
At this conference, experts on the many scientific, legal, and policy issues surrounding tobacco control gathered to share ideas for implementation by the Food and Drug Administration (FDA) of the Family Smoking Prevention and Tobacco Control Act of 2009. The FDA, which now has authority to control tobacco, has asked the public to comment on the approaches and actions it should take initially to increase the likelihood of reducing the incidence and prevalence of tobacco product use and protecting the public health. Proceedings from the conference will be filed as comments with FDA.
Prof. Stanton Glantz, Professor of Medicine and Director, Center for Tobacco Control Research and Education, UCSF, delivered the keynote address.